Hospital
University of Southern California
University of Southern California was paid $8.63M by Medicaid between Jan 2018 and Oct 2024, across 103 billing codes. Its largest line is 0450, Emergency room services — 39% of everything it billed.
33Billing provider infoUNIVERSITY OF SOUTHERN CALIFORNIA
GLENDALE, CA 91208
GLENDALE, CA 91208
33aNPI1154715845assigned 03/20/2015
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.63M
24GClaims83,904
24DCodes billed103
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#196 of 410
Median peer was paid$6.90M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,119 | $3.49M | |
| 2019 | 28,565 | $3.22M | |
| 2020 | 21,305 | $1.91M | |
| 2021 | 52 | $2K | |
| 2023 | 127 | $1K | |
| 2024incomplete | 736 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 39% | 9,265 | 8,454 | $3.37M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.7% | 587 | 566 | $841K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.0% | 840 | 820 | $520K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.9% | 2,285 | 2,148 | $427K |
| 80053 | Comprehensive metabolic panel | 4.5% | 4,657 | 4,191 | $386K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.2% | 2,930 | 2,633 | $365K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.8% | 1,835 | 1,695 | $246K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.0% | 1,505 | 1,428 | $169K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 2,457 | 2,333 | $135K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.5% | 807 | 768 | $131K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 876 | 812 | $128K |
| 84512 | 1.3% | 1,439 | 1,252 | $116K |
91 more codes
| 81025 | 1.1% | 2,101 | $93K | |
| 83690 | 1.0% | 1,659 | $90K | |
| 99283 | Emergency room visit (moderate) | 1.0% | 673 | $90K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 833 | $87K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,571 | $81K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,697 | $75K |
| J3490 | Unclassified drugs | <1% | 4,665 | $75K |
| 93017 | <1% | 160 | $72K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 498 | $69K |
| 99285 | Emergency room visit (most serious) | <1% | 127 | $65K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 56 | $61K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 788 | $59K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 960 | $57K |
| 83880 | <1% | 834 | $53K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,261 | $53K |
| 83605 | <1% | 950 | $49K | |
| 76377 | <1% | 246 | $48K | |
| 85610 | <1% | 1,537 | $38K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 171 | $37K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,329 | $35K |
| 81003 | <1% | 2,739 | $29K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 73 | $27K |
| 99199 | Unlisted special service, procedure or report | <1% | 571 | $27K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,305 | $26K |
| 87040 | <1% | 259 | $24K | |
| 81001 | <1% | 1,859 | $23K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 360 | $20K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,039 | $17K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 72 | $16K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,017 | $16K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,548 | $15K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 172 | $15K |
| 84484 | <1% | 624 | $14K | |
| 87077 | <1% | 521 | $14K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 125 | $12K |
| 0250 | <1% | 1,074 | $12K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,063 | $11K |
| 80306 | <1% | 169 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 551 | $11K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,051 | $10K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 25 | $9K |
| 87641 | <1% | 158 | $8K | |
| 85379 | <1% | 151 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 192 | $8K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 72 | $8K |
| 94664 | <1% | 104 | $7K | |
| 94760 | <1% | 414 | $6K | |
| 96376 | <1% | 162 | $6K | |
| Z7502 | <1% | 154 | $6K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 219 | $6K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 279 | $6K |
| 87276 | <1% | 612 | $5K | |
| 82948 | <1% | 584 | $5K | |
| 0636 | <1% | 96 | $5K | |
| 0637 | <1% | 1,483 | $5K | |
| 87186 | <1% | 166 | $5K | |
| 87275 | <1% | 607 | $4K | |
| 87581 | <1% | 172 | $4K | |
| 0270 | <1% | 861 | $4K | |
| 87486 | <1% | 171 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 85 | $3K |
| 87430 | <1% | 115 | $3K | |
| 87081 | <1% | 76 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 229 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 92 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 157 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 158 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 147 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 34 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 137 | $1K |
| 85730 | <1% | 118 | $1K | |
| 0251 | <1% | 364 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 12 | $1K |
| 80061 | Lipid panel | <1% | 183 | $1K |
| 97161 | <1% | 12 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 111 | $1K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 44 | $1K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 27 | $822.14 |
| 0324 | <1% | 12 | $702.03 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 39 | $626.30 |
| 83735 | <1% | 56 | $435.29 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 64 | $337.97 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 33 | $326.75 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $251.26 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $251.08 |
| 86900 | <1% | 19 | $232.56 | |
| 86850 | <1% | 19 | $203.91 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $137.83 |
| 86901 | <1% | 19 | $112.30 | |
| 84100 | <1% | 19 | $103.27 | |
| A9270 | Non-covered item or service | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACKIEWICZ, THOMAS (SVP & CEO, KECK MEDICINE OF USC)
Parent organizationUNIVERSITY OF SOUTHERN CALIFOR
| Provider | Location | Paid |
|---|---|---|
| University of Southern California | Los Angeles, CA | $19.48M |
| University of Southern California | Los Angeles, CA | $15.43M |
| University of Southern California | Alhambra, CA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.